Synopsys stock has dropped about 33.4% over the past year, yet the company’s own Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading below that internal fair value, while traditional earnings multiples suggest the stock is expensive. This split between the DCF signal and the richer read from market multiples leaves Synopsys looking neither like a straightforward bargain nor a clear avoid on valuation.

• Over the last 12 months, Synopsys has declined roughly 33.4%, which means investors are now reassessing whether the current price fairly reflects the company’s prospects.
• Fresh interest in Synopsys’ AI powered chip design tools and closer ties with major semiconductor players can support growth expectations, while legal disputes and integration risks tied to the Ansys acquisition may weigh on how much value the market is willing to place on that potential.
• With Synopsys screening attractive on only 2 of 6 valuation checks, the broader score leans towards the stock being on the expensive side rather than an obvious bargain.

The issue now is whether the DCF implied upside or the richer earnings multiple view will prove to be the better guide for what Synopsys is worth today.

Is Synopsys Still Cheap on Cash Flow?

The Discounted Cash Flow model values Synopsys by projecting future free cash flows and discounting them back to today. Synopsys currently generates about $2.6b in free cash flow over the last twelve months, and the model assumes these cash flows keep growing rather than shrinking.

On those cash flow projections, the DCF points to an estimated intrinsic value of about $511 per share, which implies the stock is roughly 19.4% below that level on this measure. Because Synopsys has certified its AI powered design tools for Intel’s upcoming 14A node and reported recent revenue growth, the current discount may partly reflect investor caution around sustaining those cash flows while also handling Ansys integration and legal risks.

On this cash flow view, Synopsys stock appears undervalued relative to its DCF based intrinsic value estimate.

Our Discounted Cash Flow (DCF) analysis suggests Synopsys is undervalued by 19.4%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Has Synopsys Run Too Far on Earnings?

P/E is a useful cross check for Synopsys because earnings still sit at the center of how many investors think about what they are paying for each dollar of profit. On this measure, Synopsys trades on a P/E of about 102.0x, compared with a Software industry average of roughly 32.8x and a peer group average near 34.5x.

The fair P/E ratio implied by the broader model is about 51.3x, which already incorporates the company’s growth profile, margins, scale and risk factors. The current 102.0x is almost double that fair multiple. This indicates that the market is assigning a rich premium to Synopsys despite the legal and integration issues flagged around the Ansys deal. Even allowing for interest in Synopsys AI enabled chip design tools and recent earnings momentum, this suggests that investors are paying a high price for each dollar of earnings on this metric.

On the earnings multiple alone, Synopsys stock appears overvalued relative to both its tailored fair P/E and typical Software peers.

The Synopsys Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Synopsys help you connect the current valuation puzzle to the specific future paths that could make the stock look meaningfully cheaper or richer than today’s price. They sit on Synopsys' Community page and set out the earnings, growth and margin outcomes that would need to play out for different scenarios. Where a single ratio or model offers one number, these narratives unpack the future it depends on so you can keep track of whether it is still on course.

If you have a number driven view on whether Synopsys' AI powered design tools and deeper ties with Intel, Microsoft, AMD and Nvidia will justify today’s valuation, share a Narrative on the Community page to add your voice to the discussion. It can help you track how your thesis holds up as new results and industry updates come through.

Do you think there's more to the story for Synopsys? Head over to our Community to see what others are saying!

The Bottom Line

Synopsys sits in an awkward middle ground. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside from today’s price, yet the rich P/E and weak broader valuation checks argue the stock already carries a heavy optimism premium. That gap largely reflects a DCF that leans on cash flow durability, while the market multiple leans on very strong growth expectations. The key question from here is whether Synopsys can turn interest in its AI powered design tools into sustained earnings and margin delivery that justify both the premium multiple and the DCF implied upside, despite legal and integration risks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.